Unsere Publikationen

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

Link
https://doi.org/10.1177/2055217320972137
Tags
Multiple SkleroseMS Behandlung
Jahr
2020
Autoren
Horáková D, Boster A, Bertolotto A, Freedman MS, Firmino I, Cavalier SJ, Jacobs AK, Thangavelu K, Daizadeh N, Poole EM, Baker DP, Margolin DH, Ziemssen T; CARE-MS I, CARE-MS II, and CAMMS03409 Investigators.
Verlag
Mult Scler J Exp Transl Clin. 2020 Dec 18;6(4):2055217320972137.
Zum Eintrag

On the reliability of examining dual-tasking abilities using a novel e-health device – a proof of concept study in multiple sclerosis

Link
https://doi.org/10.3390/jcm9113423
Tags
Management & ScienceeHealth
Jahr
2020
Autoren
Böttrich N, Mückschel M, Dillenseger A, Lange C, Kern R, Ziemssen T, Beste C.
Verlag
J Clin Med. 2020 Oct 25;9(11):3423.
Zum Eintrag

Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis

Link
https://doi.org/10.3389/fimmu.2020.00056
Tags
Multiple SkleroseMS BehandlungNeuroimmunologie
Jahr
2020
Autoren
Akgün K, Blankenburg J, Marggraf M, Haase R, Ziemssen T.
Verlag
Front Immunol 2020;11.
Zum Eintrag

Pneumocystis pneumonia in a patient treated with alemtuzumab for relapsing multiple sclerosis

Link
https://doi.org/10.1016/j.msard.2019.101503
Tags
Multiple SkleroseMS Behandlung
Jahr
2020
Autoren
Lau AY, Lui GCY, Chan K-, Au C, Mok VCT, Ziemssen T.
Verlag
Mult Scler Relat Disord 2020;38.
Zum Eintrag

Antigen-shift in varicella-zoster virus-specific T-cell immunity over the course of Fingolimod-treatment in relapse-remitting multiple sclerosis patients

Link
https://doi.org/10.1016/j.msard.2019.101859
Tags
Multiple SkleroseMS BehandlungNeuroimmunologie
Jahr
2020
Autoren
Matko S, Akgün K, Tonn T, Ziemssen T, Odendahl M.
Verlag
Mult Scler Relat Disord 2020;38.
Zum Eintrag

A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians’ and patients’ views

Link
https://doi.org/10.1016/j.msard.2019.101861
Tags
Multiple Sklerose
Jahr
2020
Autoren
Ziemssen T, Tolley C, Bennett B, Kilgariff S, Jones E, Pike J, Tomic D, Piani-Meier D, Lahoz R.
Verlag
Mult Scler Relat Disord. 2020 Feb;38:101861.
Zum Eintrag

Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study

Link
https://doi.org/10.1007/s40263-020-00700-0
Tags
Multiple SkleroseMS Behandlung
Jahr
2020
Autoren
Naismith RT, Wundes A, Ziemssen T, Jasinska E, Freedman MS, Lembo AJ, Selmaj K, Bidollari I, Chen H, Hanna J, Leigh-Pemberton R, Lopez-Bresnahan M, Lyons J, Miller C, Rezendes D, Wolinsky JS; EVOLVE-MS-2 Study Group.
Verlag
CNS Drugs. 2020 Feb;34(2):185-196.
Zum Eintrag

A physician-completed digital tool for evaluating disease progression (multiple sclerosis progression discussion tool): Validation study

Link
https://doi.org/10.2196/16932
Tags
Multiple SkleroseManagement & ScienceeHealth
Jahr
2020
Autoren
Ziemssen T, Piani-Meier D, Bennett B, Johnson C, Tinsley K, Trigg A, Hach T, Dahlke F, Tomic D, Tolley C, Freedman MS.
Verlag
J Med Internet Res. 2020 Feb 12;22(2):e16932.
Zum Eintrag

Publikationen durchsuchen

Publikationen filtern

Filters
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Show AllHide
Jahr
-